Brief: Hofseth Biocare Q3 Revenue NOK 49.9 Million
10/11/2023 07:02
Nov 10 (Reuters) - Hofseth Biocare Q3 revenue NOK 49.9 million. * Q3 EBIT NOK -25.2 million
Recent news on Hofseth Biocare ASA
See all newsBrief: HBC Publishes Clinical Trial, Calls It Paradigm-Changing
Brief: Hofseth Biocare Says Demand Outlook For 2026 Is Improving Rapidly
Norway's Hofseth Biocare Q4 revenue rises on Human Nutrition demand
Brief: Hofseth BioCare To Cancel Subsequent Offering
Brief: Hofseth Biocare Announces Results Of Subsequent Offering